2689.T

OLBA HEALTHCARE HOLDINGS, Inc. [2689.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

2689.T Stock Summary

Earnings are expected to fall -100% next year

2689.T has less than 1 year of cash runway

Top 10 Correlated ETFs

2689.T

Top 10 Correlated Stocks

2689.T

In the News

2689.T Financial details

Company Rating

Buy

Market Cap

11.99B

Income

1.35B

Revenue

114.22B

Book val./share

1699.28

Cash/share

488.88

Dividend

Dividend %

3.83%

Employees

1.32K

Optionable

Shortable

Yes

Earnings

26 Apr 2024

P/E

8.3

Forward P/E

PEG

-7.5

P/S

0.1

P/B

1.1

P/C

3.97

P/FCF

Quick Ratio

0.81

Current Ratio

1.17

Debt / Equity

0.27

LT Debt / Equity

EPS (TTM)

224.81

EPS next Y

EPS next Q

EPS this Y

-7.08%

EPS next Y

EPS next 5Y

EPS last 5Y

11.19%

Revenue last 5Y

0.56%

Revenue Q/Q

EPS Q/Q

90.54%

SMA20

1.42%

SMA50

7.33%

SMA100

12.38%

Inst Own

Inst Trans

ROA

ROE

14%

ROC

0.17%

Gross Margin

12%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1685.0-2069.0

52W High

-6.14%

52W Low

+15.25%

RSI

Rel Volume

0.65

Avg Volume

4.95K

Volume

3.2K

Perf Week

-4.8%

Perf Month

2.37%

Perf Quarter

5.09%

Perf Half Y

5.49%

Beta

0.451

Volatility

32.41%, 51.27%

Prev Close

-1.42%

Price

1942

Change

-1.92%

2689.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	19.15K	18.76K	18.57K	17.78K	18.35K
Net income per share	138.24	56.76	162.66	252.8	234.9
Operating cash flow per share	24.37	150	514	398.57	-109.55
Free cash flow per share	-72.51	70.79	409.92	323.93	-151.24
Cash per share	-39.78	95.32	96.42	298.79	132.58
Book value per share	1.19K	1.27K	1.34K	1.5K	1.72K
Tangible book value per share	1.13K	1.18K	1.22K	1.36K	1.6K
Share holders equity per share	1.19K	1.27K	1.34K	1.5K	1.72K
Interest debt per share	472.33	685.03	325.95	214.86	322.07
Market cap	7.6B	7.79B	10.07B	10.17B	10.89B
Enterprise value	9.11B	9.77B	9.87B	8.27B	10.41B
P/E ratio	9.8	23.85	10.17	6.63	7.7
Price to sales ratio	0.07	0.07	0.09	0.09	0.1
POCF ratio	55.6	9.03	3.22	4.2	-16.5
PFCF ratio	-18.69	19.13	4.04	5.17	-11.95
P/B Ratio	1.14	1.07	1.24	1.12	1.05
PTB ratio	1.14	1.07	1.24	1.12	1.05
EV to sales	0.08	0.09	0.09	0.08	0.09
Enterprise value over EBITDA	5.38	7.28	5.02	3.13	3.88
EV to operating cash flow	66.64	11.33	3.16	3.42	-15.78
EV to free cash flow	-22.4	24.01	3.96	4.2	-11.43
Earnings yield	0.1	0.04	0.1	0.15	0.13
Free cash flow yield	-0.05	0.05	0.25	0.19	-0.08
Debt to equity	0.39	0.54	0.24	0.14	0.19
Debt to assets	0.08	0.12	0.05	0.03	0.05
Net debt to EBITDA	0.89	1.48	-0.1	-0.72	-0.18
Current ratio	1.11	1.12	1.11	1.14	1.18
Interest coverage	61.83	35.1	69.73	101.04	120.55
Income quality	0.12	1.19	2.07	1.13	-0.31
Dividend Yield	0.03	0.03	0.03	0.03	0.03
Payout ratio	0.29	0.7	0.28	0.2	0.26
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.01	0.01	0.02	0.02	0.02
Capex to operating cash flow	-3.98	-0.53	-0.2	-0.19	0.38
Capex to revenue	-0.01	0	-0.01	0	0
Capex to depreciation	-1.5	-1.11	-1.57	-1.12	-0.49
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.93K	1.27K	2.21K	2.92K	3.01K
ROIC	0.08	0.02	0.09	0.13	0.11
Return on tangible assets	0.02	0.01	0.03	0.04	0.04
Graham Net	-1.72K	-1.68K	-1.82K	-1.73K	-1.72K
Working capital	2.67B	2.93B	2.99B	4.04B	5.15B
Tangible asset value	6.34B	6.78B	7.43B	8.28B	9.62B
Net current asset value	730.2M	323.71M	674.45M	2.03B	3.19B
Invested capital	0.39	0.54	0.24	0.14	0.19
Average receivables	20.06B	19.14B	18.33B	19.87B	21.39B
Average payables	16.28B	15.32B	15.32B	17.24B	18.03B
Average inventory	4.63B	5.04B	5.42B	5.51B	5.88B
Days sales outstanding	69.11	60.72	60.48	71.08	71.9
Days payables outstanding	61.83	54.01	58.7	69.48	66.99
Days of inventory on hand	17.65	20.42	19.55	21.38	23.06
Receivables turnover	5.28	6.01	6.04	5.14	5.08
Payables turnover	5.9	6.76	6.22	5.25	5.45
Inventory turnover	20.68	17.87	18.67	17.08	15.83
ROE	0.12	0.04	0.12	0.17	0.14
Capex per share	-96.88	-79.21	-104.07	-74.65	-41.69

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q2

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	4.56K	4.84K	4.58K	4.56K	5.01K
Net income per share	49.24	80.66	63.09	27.9	53.16
Operating cash flow per share	44.19	43.33	46.89	40.89	46.25
Free cash flow per share	44.19	43.33	46.89	40.89	46.25
Cash per share	439.95	433.97	132.33	431.35	488.88
Book value per share	1.54K	1.62K	1.71K	1.66K	1.7K
Tangible book value per share	1.42K	1.5K	1.6K	1.54K	1.58K
Share holders equity per share	1.54K	1.62K	1.71K	1.66K	1.7K
Interest debt per share	377.31	317.79	319.13	448.25	452.64
Market cap	9.3B	10.53B	10.91B	10.9B	10.63B
Enterprise value	8.92B	9.83B	10.43B	10.99B	11.58B
P/E ratio	7.85	5.42	7.16	16.18	8.37
Price to sales ratio	0.34	0.36	0.39	0.4	0.35
POCF ratio	34.99	40.34	38.55	44.17	38.47
PFCF ratio	34.99	40.34	38.55	44.17	38.47
P/B Ratio	1	1.08	1.06	1.09	1.05
PTB ratio	1	1.08	1.06	1.09	1.05
EV to sales	0.33	0.34	0.38	0.4	0.39
Enterprise value over EBITDA	19.41	13.62	17.82	43.26	18.26
EV to operating cash flow	33.55	37.64	36.86	44.56	41.91
EV to free cash flow	33.55	37.64	36.86	44.56	41.91
Earnings yield	0.03	0.05	0.03	0.02	0.03
Free cash flow yield	0.03	0.02	0.03	0.02	0.03
Debt to equity	0.24	0.2	0.19	0.27	0.27
Debt to assets	0.06	0.05	0.05	0.07	0.06
Net debt to EBITDA	-0.83	-0.98	-0.82	0.38	1.5
Current ratio	1.15	1.16	1.18	1.17	1.16
Interest coverage	94.76	148.89	152.37	53.41	97.19
Income quality	0.9	0.54	0.74	1.47	0.87
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0.01	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.02	0.02	0.02	0.02	0.02
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.31K	1.72K	1.56K	1.02K	1.43K
ROIC	0.03	0.04	0.03	0.01	0.02
Return on tangible assets	0.01	0.01	0.01	0	0.01
Graham Net	-1.56K	-1.49K	-1.72K	-1.58K	-1.25K
Working capital	4.4B	4.83B	5.15B	4.92B	5.06B
Tangible asset value	8.53B	9.04B	9.62B	9.31B	9.45B
Net current asset value	2.47B	2.86B	3.19B	2.98B	3.05B
Invested capital	0.24	0.2	0.19	0.27	0.27
Average receivables	20.91B	22.35B	22.44B	21.54B	23.73B
Average payables	17.88B	19.05B	18.86B	17.86B	22.33B
Average inventory	6.08B	6.25B	6.26B	6.29B	6.51B
Days sales outstanding	70.83	71.41	70.91	69.8	78.48
Days payables outstanding	67.81	69.35	66.42	65.61	90.86
Days of inventory on hand	22.81	22.24	22.86	23.65	22.31
Receivables turnover	1.27	1.26	1.27	1.29	1.15
Payables turnover	1.33	1.3	1.35	1.37	0.99
Inventory turnover	3.95	4.05	3.94	3.8	4.03
ROE	0.03	0.05	0.04	0.02	0.03
Capex per share	0	0	0	0	0

2689.T Dividend History

2689.T Frequently Asked Questions

What is OLBA HEALTHCARE HOLDINGS, Inc. stock symbol ?

OLBA HEALTHCARE HOLDINGS, Inc. is a JP stock and trading under the symbol 2689.T

What is OLBA HEALTHCARE HOLDINGS, Inc. stock quote today ?

OLBA HEALTHCARE HOLDINGS, Inc. stock price is $1942 today.

Is OLBA HEALTHCARE HOLDINGS, Inc. stock public?

Yes, OLBA HEALTHCARE HOLDINGS, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 4.95K
Market Capitalization 11.99B
Employee 1.32K
CEO Mr. Yohei Maeshima
Headquarters Okayama,JP
IPO Date 2001-01-04
Website https://www.olba.co.jp

OLBA HEALTHCARE HOLDINGS, Inc. provides various solutions to medical institutions, universities, corporate research institutes, individuals, and long-term care facilities in Japan. The company's medical equipment business engages in the wholesale of artificial joints, pacemakers, coronary stents, steel instruments, and ultrasonic scalpels; and diagnostic imaging equipment, such as MRI and CT to respirators, intraoperative monitors, and surgical lights. It also offers reagents and equipment for genetic research, cell culture, and protein analysis; automatic analyzers for biochemistry, immunity, and blood; and test reagents, as well as undertakes services for DNA analysis in the field of life sciences. The company's Supply Processing and Distribution business provides goods management, information management, and purchase management services. Its Nursing care products business engages in the rental of nursing care equipment; sale of welfare equipment, such as portable toilets and bathing equipment; and operation of long-term care reform, a comfortable stay at home. The company was formerly known as Kawanishi Holdings, Inc. and changed its name to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021. OLBA HEALTHCARE HOLDINGS, Inc. was founded in 1921 and is headquartered in Okayama, Japan.